Prosecution Insights
Last updated: September 17, 2026

Skyhawk Therapeutics Inc.

7 pending office actions • 1 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
6
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (14%)
5
Medium (71%)
1
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (14%)
Double-patenting + other5 (71%)
Multi-statute (no §101)1 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
7
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEE, CHIHYI NMN 2 34.1% +60.6%
DIAMOND, ALAN D 1 71.1% +9.2%
NESTOR, DONNA MICHELLE 1 56.8% +45.8%
CHANDRAKUMAR, NIZAL S 1 72.7% +18.3%
MOORE, SUSANNA 1 68.0% +31.6%
FETTEROLF, BRANDON J 1 51.8% +17.5%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19177271 METHODS AND COMPOSITIONS FOR MODULATING SPLICING DIAMOND, ALAN D —

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18864030 COMPOSITIONS USEFUL FOR MODULATING SPLICING NESTOR, DONNA MICHELLE —
18864033 COMPOSITIONS USEFUL FOR MODULATING SPLICING CHANDRAKUMAR, NIZAL S —
18858878 COMPOSITIONS USEFUL FOR MODULATING SPLICING MOORE, SUSANNA —
18707167 COMPOSITIONS USEFUL FOR MODULATING SPLICING LEE, CHIHYI NMN —
18707166 COMPOSITIONS USEFUL FOR MODULATING SPLICING FETTEROLF, BRANDON J —
18707168 COMPOSITIONS USEFUL FOR MODULATING SPLICING LEE, CHIHYI NMN —

Top Art Units

Art UnitApps
3991 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19177271 METHODS AND COMPOSITIONS FOR MODULATING SPLICING DIAMOND, ALAN D 3991 §102§103§112 Final Rejection — Pending Apr 11, 2025
18864030 COMPOSITIONS USEFUL FOR MODULATING SPLICING NESTOR, DONNA MICHELLE — §102§112DP Non-Final OA — Pending Nov 08, 2024
18864033 COMPOSITIONS USEFUL FOR MODULATING SPLICING CHANDRAKUMAR, NIZAL S — §112DP Non-Final OA — Pending Nov 08, 2024
18858878 COMPOSITIONS USEFUL FOR MODULATING SPLICING MOORE, SUSANNA — §112DP Non-Final OA — Pending Oct 22, 2024
18707167 COMPOSITIONS USEFUL FOR MODULATING SPLICING LEE, CHIHYI NMN — §103§112DP Non-Final OA — Pending May 03, 2024
18707166 COMPOSITIONS USEFUL FOR MODULATING SPLICING FETTEROLF, BRANDON J — §112 Non-Final OA — Pending May 03, 2024
18707168 COMPOSITIONS USEFUL FOR MODULATING SPLICING LEE, CHIHYI NMN — §103§112DP Non-Final OA — Pending May 03, 2024

Managing Skyhawk Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month